Phenylalanine 4-monooxygenase and the role of endobiotic metabolism enzymes in xenobiotic biotransformation

Bibliography

• Roberts SA. High-throughput screening approaches for investigating drug metabolism and pharmacokinetics. Xenobiotica 2001;31:557-89
   PubMed Web of Science ®Google Scholar
• Clarke SE, Jefferey P. Utility of metabolic stability screening: comparison of in vitro and in vivo clearance. Xenobiotica 2001;31:591-98
   PubMed Web of Science ®Google Scholar
• Fitzpatrick PF. Tetrahydropterin-dependent amino acid hydroxylases. Annu Rev Biochem 1999;68:355-81
   PubMed Web of Science ®Google Scholar
• Pey AL, Ying M, Cremades N, et al. Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria. J Clin Invest 2008;118:2858-67
   PubMed Web of Science ®Google Scholar
• PAHdb, 2009. McGill University, Canada, PAHdb Phenylalanine hydroxylase Locus Knowledgebase. Available from: http://www.pahdb.mcgill.ca
   Google Scholar
• Kaufman S, Mason K. Specificity of amino acids as activators and substrates for phenylalanine hydroxylase. J Biol Chem 1982;257:14667-78
   PubMed Web of Science ®Google Scholar
• Hufton SE, Jennings IG, Cotton RG. Structure and function of the aromatic amino acid hydroxylases. Biochem J 1995;311:353-66
   PubMed Web of Science ®Google Scholar
• Goreish AH, Bednar S, Jones H, et al. Phenylalanine 4-monooxygenase and the S-oxidation of S-carboxymethyl-L-cysteine. Drug Metabol Drug Interact 2004;20:159-74
   PubMedGoogle Scholar
• Boonyapiwat B, Panagopoulos P, Jones H, et al. Phenylalanine 4-monooxygenase and the S-oxidation of S-carboxymethyl-L-cysteine in HepG2 cells. Drug Metabol Drug Interact 2005;21:1-18
   PubMed Web of Science ®Google Scholar
• Patel GL, Illoudi C, Boonyapiwat B, et al. Enzyme kinetic and molecular modelling studies of sulphur containing substrates of phenylalanine 4-monooxygenase. J Enzyme Inhib Med Chem 2008;23:958-63
   PubMed Web of Science ®Google Scholar
• Jacob C, Lancaster JR, Giles GI. Reactive sulphur species in oxidative signalling transduction. Biochem Soc Trans 2004;32:1015-17
   PubMed Web of Science ®Google Scholar
• Ying J, Clavreul N, Sethuraman M, et al. Thiol oxidation in signalling and response to stress: Detection and quantification of physiological and pathophysiological thiol modifications. Free Rad Biol Med 2007;43:1099-108
   PubMed Web of Science ®Google Scholar
• Jassen-Heininger YMW, Mossman BT, Heintz NH, et al. Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radic Biol Med 2008;45:1-17
   PubMed Web of Science ®Google Scholar
• Mitchell SC, Waring RH, Haley CS, et al. Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man. Brit J clin Pharmacol 1984;18:507-21
   PubMed Web of Science ®Google Scholar
• Mitchell SC, Waring RH. The deficiency of sulfoxidation of S-carboxymethyl-L-cysteine. Pharmacol Therap 1989;43:237-49
   PubMed Web of Science ®Google Scholar
• Steventon GB. Diurnal variation in the metabolism of S-carboxymethyl-L-cysteine in man. Drug Metab Dispos 1999;27:1092-7
   PubMed Web of Science ®Google Scholar
• Waring RH, Mitchell SC, O'Gorman J, Fraser M. Cytosolic sulphoxidation of S-carboxymethyl-L-cysteine in mammals. Biochem Pharmacol 1986;35:2999-3002
   PubMed Web of Science ®Google Scholar
• Khan S, Mitchell SC, Steventon GB. Lack of congruence between cysteine dioxygenase activity and S-carboxymethyl-L-cysteine S-oxidation activity in rat cytosol. J Pharm Pharmacol 2004;56:993-1000
   PubMed Web of Science ®Google Scholar
• Boonyapiwat B, Forbes B, Mitchell SC, Steventon GB. Phenylalanine 4-monooxygenase and the S-oxidation of S-carboxymethyl-L-cysteine by human cytosolic fractions. Drug Metabol Drug Interact 2008;23:261-82
   PubMedGoogle Scholar
• Boonyapiwat B, Panaretou B, Forbes B, et al. Human phenylalanine monooxygenase and thioether metabolism. J Pharm Pharmacol 2009;61:63-7
   PubMed Web of Science ®Google Scholar
• Steventon GB, Mitchell SC, Pérez B, et al. The activity of wild type and mutant phenylalanine hydroxylase with respect to the C-oxidation of phenylalanine and the S-oxidation of S-carboxymethyl-L-cysteine. Mol Genet Metab 2009;96:27-31
   PubMed Web of Science ®Google Scholar
• Steventon GB, Mitchell SC. Mouse recombinant phenylalanine monooxygenase and the S-oxygenation of thioether substrates. Biochem Mol Toxicol 2009;23:119-24
   PubMed Web of Science ®Google Scholar
• Teigen K, Froystein NA, Martinez A. The structural basis of the recognition of phenylalanine and pterin cofactors by phenylalanine hydroxylase: implications for the catalytic mechanism. J Mol Biol 1999;294:807-23
   PubMed Web of Science ®Google Scholar
• Chritensen R, Kolvraa S, Blaese RM, Jensen TG. Development of a skin-based metabolic sink for phenylalanine by the over expression of phenylalanine hydroxylase and GTP cyclohydrolase in primary human keratinocytes. Gene Ther 2000;7:1971-78
   PubMed Web of Science ®Google Scholar
• Ledley FD, Grenett HE, Woo SLC. Biochemical characterization of recombinant human phenylalanine hydroxylase produced in Escherichia coli. J Biol Chem 1987;262:2228-33
   PubMed Web of Science ®Google Scholar
• Pérez B, Desviat LR, Gómez-Puertas P, et al. Kinetic and stability analysis of PKU mutations identified in BH4-responsive patients. Mol Genet Metab 2005;86:S11-16
   PubMed Web of Science ®Google Scholar
• Scriver CR, Kaufman S. Hyperphenylalaninemias: phenylalanine hydroxylase deficiency. In: Scriver CR, Beaudet al, Valle D, Sly WS, editors, the metabolic and molecular bases of inherited diseases, McGraw-Hill, New York, 2001. p. 1667-724
   Google Scholar
• Bradley H, Gough A, Sokhi RS, et al. Sulfate metabolism is abnormal in patients with rheumatoid arthritis. Conformation by in vivo biochemical findings. J Rheumatol 1994;21:1192-6
   PubMed Web of Science ®Google Scholar
• Waring RH, Mitchell SC, Shah RR. The metabolism of S-carboxymethyl-L-cysteine in man: isolation of an ester glucuronic acid conjugate from urine. Xenobiotica 1983;13:311-17
   PubMed Web of Science ®Google Scholar
• Steventon GB, Heafield MTE, Waring RH, Williams AC. Xenobiotic metabolism in Parkinson's disease. Neurology 1989;39:883-7
   PubMed Web of Science ®Google Scholar
• Steventon GB, Williams AC, Waring RH, et al. Xenobiotic metabolism in Motorneuron disease. Lancet 1988;II:644-7
   Google Scholar
• Steventon GB, Heafield MTE, Sturman S, et al. Xenobiotic metabolism in Alzheimer's disease. Neurology 1990;40:1095-8
   PubMed Web of Science ®Google Scholar
• Emery P, Bradley H, Arthur V, et al. ‘Genetic factors influencing the outcome of early arthritis–the role of sulphoxidation status’. Br J Rheumatol 1993;32:170-2
   Google Scholar
• Heafield MTE, Fearn S, Steventon GB, et al. Plasma cysteine and sulphate levels in patients with Motorneurone, Parkinson's and Alzhemier's disease. Neurosci Letts 1990;110:216-20
   PubMed Web of Science ®Google Scholar
• Camu W, Billiard M, Baldy-Moulinier M. Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis. Acta Neurol Scand 1993;88:51-5
   PubMed Web of Science ®Google Scholar
• Haefele MJ, White G, McDonald JD. Characterization of the mouse phenylalanine hydroxylase mutation Pahenu3. Mol Genet Metab 2001;72:27-30
   PubMed Web of Science ®Google Scholar
• Fukushima N, Ishii I, Contas JJA, et al. Lysophospholipid receptors. Ann Rev Pharmacol Toxicol 2001;41:507-34
   PubMed Web of Science ®Google Scholar
• Zou C-G, Banerjee R. Tumor necrosis factor-α-induced targeted proteolysis of cystathionine β-synthase modulates redox homeostasis. J Biol Chem 2003;278:16802-8
   PubMed Web of Science ®Google Scholar